Recent Research Funding

We receive funding from a variety of sources that recognize the value of our high-impact research.

  • Epigenetic Mechanisms That Drive Genetic Risk for Juvenile Arthritis. James Jarvis (Principal Investigator). NIH/NIAMS. $3,047,449. 10/1/2022-9/1/2027.
  • Effects of pulse consumption on maternal and child health. Xiaozhong Wen (Principal Investigator). United States Department of Agriculture. $500,260. 8/1/2021-7/1/2026.
  • Optimizing Chest Compressions for Bradycardia during Neonatal Resuscitation. Praveen Chandrasekharan (Principal Investigator). R01 - Eunice Kennedy Shriver National Institute of Child Health & Human Development. $1,500,000. 5/1/2021-4/1/2026.
  • A 5-Year Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions. Heather Lehman (Principal Investigator). TARGET PharmaSolutions, Inc. 1/1/2020-12/1/2025.
  • Symptom Screening Linked to Care Pathways for Children with Cancer: a Cluster Randomized Trial. Kara Kelly (Contributor). National Cancer Institute. 8/1/2020-7/1/2025.
  • Symptom Screening Linked to Care Pathways for Children with Cancer: a Cluster Randomized Trial. Kara Kelly (Contributor). CIHR. 4/1/2020-3/1/2025.
  • The Margaret L. Wendt Foundation Equipment Grant. Taosheng Huang (Principal Investigator). The Margaret L. Wendt Foundation. $338,000. 12/1/2021-12/1/2024.
  • Billing & Equity- financial viability of coaching and enabling equity of healthcare across the pediatric diabetes population. Kathleen Bethin (Principal Investigator). The Leona M. and Harry B. Helmsley Charitable Trust. $1,436,000. 12/1/2021-12/1/2024.
  • Optimizing the duration of delayed umbilical cord clamping during preterm resuscitation using an asphyxiated model. Praveen Chandrasekharan (Co-Principal Investigator). ZOLL Foundation. $80,000. 9/1/2022-6/1/2024.
  • Molecular Mechanism of Biallelic Mutations of FDXR Causing Novel Mitochondriopathy with Optic Atrophy. Taosheng Huang (Principal Investigator). NIH-National Eye Institute. $1,250,000. 4/1/2019-3/1/2024.
  • Exploiting Replication Stress in Ewing Sarcoma. Ajay Gupta (Principal Investigator). Hyundai Hope on Wheels. 1/1/2022-12/1/2023.
  • Determinants and health effects of dynamic changes in e-cigarette use before, during, and after pregnancy. Xiaozhong Wen (Principal Investigator). NIH/NIDA. $455,585. 12/1/2021-11/1/2023.
  • 3D Chromatin Studies in Pediatric B Cells To Study the Genetics of Autoimmunity. James Jarvis (Principal Investigator). NIH. 11/1/2021-10/1/2023.
  • Developmental Impact of NICU Exposures (DINE). Anne Marie Reynolds (Principal Investigator). National Institutes of Health. $5,300,000. 9/1/2016-8/1/2023.
  • Improving Quality of Neonatal Resuscitation by Minimizing Interruptions. Praveen Chandrasekharan (Principal Investigator). K12 - Implementation Science - NHLBI. 8/1/2020-7/1/2023.
  • Preventing Obesity Through Interventions During Infancy. Stephanie Anzman-Frasca (Principal Investigator). Pennsylvania State University. $59,798. 6/1/2018-3/1/2023.
  • Exploration of the genetic basis and molecular mechanism for paternal mitochondrial DNA inheritance. Taosheng Huang (Principal Investigator). NIH-National Institute of Child Health & Development. $1,200,000. 4/1/2018-3/1/2023.
  • Use of shared antibody responses amongst Alzheimer's Disease patients to reveal an infectious disease etiology. Mark Hicar (Principal Investigator). IDSA. $100,000. 1/1/2022-1/1/2023.
  • Effects of Chest Compression in a Neonatal Model of Asphyxia Induced Bradycardia. Praveen Chandrasekharan (Principal Investigator). American Academy of Pediatrics - Neonatal Resuscitation Program. $50,000. 1/1/2020-12/1/2022.
  • Single Arm, Open-Label, Multicenter, Registry Study of Revcovi (elapegademase-lvlr) Treatment in ADA-SCID Patients Requiring Enzyme Replacement Therapy. Heather Lehman (Principal Investigator). Chiesi s.P.a. 12/1/2019-12/1/2022.